YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
20th Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2018
Topics And Speakers:
Session 1: Valve Disease – Focus on Aortic Stenosis I
Aortic Stenosis: What Criteria Directs Which Treatment? | David Rubenson, MD, FACC, FASE |
Mechanism of Aortic Stenosis: Degenerative, Atherosclerosis, or Inflammation | Gian M. Novaro, MD, FACC, FASE |
TAVR Is a Team Sport: The Dynamics of the Heart Valve Team | Stephanie Mick, MD |
3D Echo and MDCT Imaging for TAVR | Milind Desai, MD |
Is TAVR Applicable in Lower Risk Groups? | Jonathon White, MD |
Paravalvular Regurgitation in TAVR: Prediction, Prevention, Quantitation and Management | Linda Gillam, MD, MPH, FACC, FASE, FESC |
Valve in Valve TAVR – Another Plus for Bioprostheses at First Operation? | Robert Cubeddu, MD |
Session 2: Valve Disease—Focus on Aortic Stenosis II
Intraprocedural TEE in SAVR and TAVR: Incremental Benefit or Essential Tool? | Linda Gillam, MD, MPH, FACC, FASE, FESC |
Thoracic Aortic Disease – When CT, MR, TTE, TEE? | Milind Desai, MD |
Ascending Aortic Dilation – A Concomitant of Aortic Valve Disease | Gian M. Novaro, MD, FACC, FASE |
Paradoxical or Not: Low Flow, Low Gradient Aortic Stenosis (AS) | William J. Stewart, MD, FACC, FASE |
Transcatheter Procedures – What to Do When the Awful Happens | Jonathon White, MD |
Dobutamine Echo in Aortic Stenosis – Indications, Methods, Impact on Management | Brian Griffin, MD, FACC |
Panel Discussion |
Session 3: Aortic Stenosis Case Workshop
How to Do an AS Exam For Sonographers | Deborah A. Agler, ACS, RDCS, FASE |
Management of TAVR Paravalvular Leak | Robert Cubeddu, MD |
AS, HOCM, or Not? | Milind Desai, MD |
Watchman LAA Closure | Konstantinos P. Koulogiannis, MD |
Severe Aortic Stenosis | Stephanie Mick, MD |
Session 4: Diastolic Dysfunction and Right Heart Function I
Updated Guidelines for Assessment of LV Filling Pressure | Sherif Nagueh, MD |
Practical Approach to Diastolic Function: Limitations and Pitfalls | Deborah A. Agler, ACS, RDCS, FASE |
Estimating LV Filling Pressures By Echocardiography | Milind Desai, MD |
Constriction and Amyloid: Diastolic Dysfunction | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
Diastolic Dysfunction and LVOT Gradients in Hypertrophic Cardiomyopathy | Sherif Nagueh, MD |
Hemodynamic Correlates of Diastolic Dysfunction: What do the Studies Show? | Sherif Nagueh, MD |
Diastolic Dysfunction in Special Populations: Atrial Fibrillation, MV Disease, Transplant, Pulmonary Hypertension | William J. Stewart, MD, FACC, FASE |
Panel Discussion |
Session 5: Diastolic Dysfunction and Right Heart Function II
Athletic Heart vs. Varied Faces of Hypertrophic Cardiomyopathy | Milind Desai, MD |
Complicated Pericarditis: A New Imaging Guided Approach | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
Clinical Presentation of Right Sided Heart Disease – “Look-alikes” | Linda Gillam, MD, MPH, FACC, FASE, FESC |
Tricuspid Valve Dysfunction- Subtypes and Outcomes | David Rubenson, MD, FACC, FASE |
Aortic Valve: Replace, Repair? | Stephanie Mick, MD |
Transcatheter Tricuspid Interventions: The Forgotten Valve No Longer! | Hector I. Michalena, MD, FACC, FASE |
Role of Contrast Echo in Assessing Left and Right Heart Function | Deborah A. Agler, ACS, RDCS, FASE |
Panel Discussion |
Session 6: Constriction, Restriction, Tricuspid Regurgitation and Contrast Echo Cases
Tricuspid Valve 1 | Konstantinos P. Koulogiannis, MD |
HOCM | Deborah A. Agler, ACS, RDCS, FASE |
Multivalve Disease | David Rubenson, MD, FACC, FASE |
Severe Symptomatic TR | Brian Griffin, MD, FACC |
Diastolic Heart Failure | Robert Cubeddu, MD |
Percutaneous Valvuloplasty For Mitral Stenosis | Sherif Nagueh, MD |
Cardio Oncology | Diego Sadler, MD, FACC, FACP |
Functional Tricuspid Regurgitation | William J. Stewart, MD, FACC, FASE |
Tricuspid Valve 2 | Konstantinos P. Koulogiannis, MD |
Session 7: Valve Regurgitation, 3D Echo and Strain I
State of the Art Echo Quantification of Mitral and Aortic Regurgitation | Linda Gillam, MD, MPH, FACC, FASE, FESC |
Aortic Regurgitation – Decisions Based on Clinical and Echo Data | Brian Griffin, MD, FACC |
Surgical Considerations in Mitral Regurgitation | Stephanie Mick, MD |
Asymptomatic Severe Mitral Regurgitation: Choosing the Golden Moment | William J. Stewart, MD, FACC, FASE |
Exercise Testing in Mitral or Aortic Valve Disease: What do the Guidelines Say? | David Rubenson, MD, FACC, FASE |
Mitraclip: The New Mitral Repair | Hector Michalena, MD, FACC, FASE |
Percutaneous Mitral and Tricuspid Valve Therapies and Paravalvular Leak Closure | Jonathon White, MD |
Panel Discussion |
Session 8: Valve Regurgitation, 3D Echo and Strain II
Incorporating 3D Echo and LV Strain into Routine Practice in the Echo Lab | Deborah A. Agler, ACS, RDCS, FASE |
3D Echo: How to Acquire Data with Each of 3 Vendors | Konstantinos P. Koulogiannis, MD |
Unique Skills of 3D Echo over 2D: Which Situations? | William J. Stewart, MD, FACC, FASE |
Myocardial Mechanics: Strain and Torsion in Clinical Practice | Sherif Nagueh, MD |
LV Strain in Cardio-Oncology | Diego Sadler, MD, FACC, FACP |
Muscle Mechanics in Pericardial Disease | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
Panel Discussion |
Session 9: Radiation, Contrast Echo and MR Treatment Cases
Newer Treatment Options For Recurrent Pericarditis | Chandra Kanth Ala, MD |
Transcatheter Mitral Valve Replacement | Cliff Chun Pong Wong, MD |
Will I Get Better With Heart Surgery? | Beni R. Verma, MD |
Valvular Heart Disease | Konstantinos P. Koulogiannis, MD |
P2 Prolapse Repair | Brian Griffin, MD, FACC |
Release Date: 5/15/18
CME Expiration: 5/14/20